These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 157567)

  • 21. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major factors affecting cadaver renal transplant outcome in a single center.
    Corry RJ; Oei LS; Freeman RM; Thompson JS
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():226-31. PubMed ID: 386315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ; Kwak JY; Kang CM
    Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model.
    Oh KH; Kim JY; Kim D; Lee EM; Oh HY; Seo JS; Han JS; Kim S; Lee JS; Ahn C
    Transpl Immunol; 2004 Dec; 13(4):273-81. PubMed ID: 15589740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of donor and recipient B7-1 (CD80) in allograft rejection.
    Zheng XX; Sayegh MH; Zheng XG; Li Y; Linsley PS; Peach R; Borriello F; Strom TB; Sharpe AH; Turka LA
    J Immunol; 1997 Aug; 159(3):1169-73. PubMed ID: 9233610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue typing in renal transplantation: the impact of cyclosporine.
    Benvenisty AI; Cohen DJ; Hardy MA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
    [No Abstract]   [Full Text] [Related]  

  • 29. Pretransplant platelet transfusions: their effects on renal allograft outcome and mixed lymphocyte culture reactivity.
    Cahen R; Friedel AC; Betuel H; Adeleine P; Robert F; Trolliet P; Francois B
    Transplantation; 1993 Jun; 55(6):1428-31. PubMed ID: 8516830
    [No Abstract]   [Full Text] [Related]  

  • 30. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.
    Bauma WD; Tang IY; Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422
    [No Abstract]   [Full Text] [Related]  

  • 31. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD; Morehouse DD; Meakins JL; Klassen J; Knaack J; Beaudoin JG
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation].
    Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O
    Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture.
    Jeffery JR; Guttmann RD; Charpentier B
    Clin Exp Immunol; 1976 Sep; 25(3):437-41. PubMed ID: 134860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.
    Shons AR; Etheredge EE; Callender CO; Schmidtke JR; Simmons RL; Najarian JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):464-70. PubMed ID: 4278196
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal allograft function and cytomegaly.
    Jirka J; Horcicková M; Reneltová I; Rossmann P; Seeman J; Holá V; Kocandrle V
    Proc Eur Dial Transplant Assoc; 1980; 17():407-12. PubMed ID: 6264421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLC incompatibility index for donor--recipient matching.
    Uehling DT; Hussey JL; Belzer FO; Kan C; Bach FH
    Transplant Proc; 1977 Mar; 9(1):103-5. PubMed ID: 141120
    [No Abstract]   [Full Text] [Related]  

  • 38. MLC, PHA, HLA, and DRw studies in renal allografting.
    Braun WE; Jayavant M; Dejelo C; Zachary A; Novick A; Santos N; Williams T
    Transplant Proc; 1979 Dec; 11(4):1911-3. PubMed ID: 161103
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of immunosuppressive therapy, HLA matching and donor age on long term cadaveric pediatric renal allograft survival.
    Groenewoud AF; Persijn GG; D'Amaro J; de Lange P; Cohen B
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1683-4. PubMed ID: 2652551
    [No Abstract]   [Full Text] [Related]  

  • 40. [Domino transplantation of a living-donor kidney graft affected by thrombotic microangiopathy: surgical aspects].
    Sallusto F; Kamar N; Khedis M; Gamé X; Taj K; Delisle MB; Fort M; Noury D; Durand D; Rostaing L; Rischmann P
    Prog Urol; 2009 Jul; 19(7):513-6. PubMed ID: 19559386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.